ACER PHARMA LIMITED

Active Walsall

Wholesale of pharmaceutical goods

2 employees website.com
Life sciences and medical technology Wholesale of pharmaceutical goods
A

ACER PHARMA LIMITED

Wholesale of pharmaceutical goods

Founded 7 Mar 2016 Active Walsall, England 2 employees website.com
Life sciences and medical technology Wholesale of pharmaceutical goods
Accounts Submitted 2 Dec 2025 Next due 31 Jan 2027 8 months remaining
Confirmation Submitted 26 Feb 2026 Next due 12 Mar 2027 10 months remaining
Net assets £3M £289K 2025 year on year
Total assets £6M £3M 2025 year on year
Total Liabilities £3M £3M 2025 year on year
Charges 6
6 outstanding

Contact & Details

Contact

Registered Address

Units 5-7 Tintagel Way Aldridge Walsall WS9 8ER England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for ACER PHARMA LIMITED (10045381), an active life sciences and medical technology company based in Walsall, England. Incorporated 7 Mar 2016. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2016–2025)

Cash in Bank

N/A

Decreased by £3.18k (-100%)

Net Assets

£2.69M

Increased by £289.32k (+12%)

Total Liabilities

£3.45M

Increased by £2.65M (+332%)

Turnover

N/A

Employees

2

Debt Ratio

56%

Increased by 31 (+124%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Pritchard, IanDirectorBritishEngland5629 Oct 2023Active
Yates, Jason DerickDirectorBritishEngland527 Mar 2016Active

Shareholders

Shareholders (2)

Cst Pharma Group Holdings Limited
100.0%
1
Jason Yates
0.0%
0

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Jason Yates

British

Active
Notified 6 Apr 2016
Residence England
DOB June 1973
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Group Structure

Group Structure

No group structure identified

Charges

Charges

6 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
26 Feb 2026Confirmation StatementConfirmation statement made on 26 Feb 2026 with no updates
2 Dec 2025AccountsAnnual accounts made up to 30 Apr 2025
26 Mar 2025Confirmation StatementConfirmation statement made on 6 Mar 2025 with updates
4 Dec 2024AccountsAnnual accounts made up to 31 Mar 2024
4 Jul 2024AccountsAnnual accounts made up to 31 Mar 2025
26 Feb 2026 Confirmation Statement

Confirmation statement made on 26 Feb 2026 with no updates

2 Dec 2025 Accounts

Annual accounts made up to 30 Apr 2025

26 Mar 2025 Confirmation Statement

Confirmation statement made on 6 Mar 2025 with updates

4 Dec 2024 Accounts

Annual accounts made up to 31 Mar 2024

4 Jul 2024 Accounts

Annual accounts made up to 31 Mar 2025

Recent Activity

Latest Activity

Confirmation statement made on 26 Feb 2026 with no updates

2 months ago on 26 Feb 2026

Annual accounts made up to 30 Apr 2025

5 months ago on 2 Dec 2025

Confirmation statement made on 6 Mar 2025 with updates

1 years ago on 26 Mar 2025

Annual accounts made up to 31 Mar 2024

1 years ago on 4 Dec 2024

Annual accounts made up to 31 Mar 2025

1 years ago on 4 Jul 2024